Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report.

Demirkaya SK, Alyanak B.

Psychopharmacol Bull. 2016 Mar 1;46(1):73-76.

2.
3.

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.

Umehara H, Numata S, Tajima A, Nishi A, Nakataki M, Imoto I, Sumitani S, Ohmori T.

PLoS One. 2016 Jun 9;11(6):e0157232. doi: 10.1371/journal.pone.0157232. eCollection 2016.

4.

Integrative Medicine Approach to Pediatric Obsessive-Compulsive Disorder and Anxiety: A Case Report.

Couture DC, Chung MK, Shinnick P, Curzon J, McClure MJ, LaRiccia PJ.

Glob Adv Health Med. 2016 Jan;5(1):117-21. doi: 10.7453/gahmj.2015.091. Epub 2016 Jan 1.

5.

OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.

Pittenger C, Adams TG Jr, Gallezot JD, Crowley MJ, Nabulsi N, James Ropchan, Gao H, Kichuk SA, Simpson R, Billingslea E, Hannestad J, Bloch M, Mayes L, Bhagwagar Z, Carson RE.

J Affect Disord. 2016 May 15;196:87-96. doi: 10.1016/j.jad.2016.02.021. Epub 2016 Feb 9.

6.

Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies.

McLean CP, Zandberg LJ, Van Meter PE, Carpenter JK, Simpson HB, Foa EB.

J Clin Psychiatry. 2015 Dec;76(12):1653-7. doi: 10.4088/JCP.14m09513.

7.

Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment.

Zink M.

Adv Med. 2014;2014:317980. doi: 10.1155/2014/317980. Epub 2014 Jun 11. Review.

8.

Animal models of obsessive-compulsive disorder: utility and limitations.

Alonso P, López-Solà C, Real E, Segalàs C, Menchón JM.

Neuropsychiatr Dis Treat. 2015 Aug 4;11:1939-55. doi: 10.2147/NDT.S62785. eCollection 2015. Review.

9.

Glutamatergic agents for OCD and related disorders.

Pittenger C.

Curr Treat Options Psychiatry. 2015 Sep;2(3):271-283.

10.
11.

Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.

Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, Kelmendi B, Sanacora G, Coric V.

J Clin Psychiatry. 2015 Aug;76(8):1075-84. doi: 10.4088/JCP.14m09123.

12.

In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.

Rodriguez CI, Kegeles LS, Levinson A, Ogden RT, Mao X, Milak MS, Vermes D, Xie S, Hunter L, Flood P, Moore H, Shungu DC, Simpson HB.

Psychiatry Res. 2015 Aug 30;233(2):141-7. doi: 10.1016/j.pscychresns.2015.06.001. Epub 2015 Jun 6.

13.

Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.

Skarphedinsson G, Compton S, Thomsen PH, Weidle B, Dahl K, Nissen JB, Torp NC, Hybel K, Melin KH, Valderhaug R, Wentzel-Larsen T, Ivarsson T.

J Child Adolesc Psychopharmacol. 2015 Jun;25(5):432-9. doi: 10.1089/cap.2014.0167.

14.

Comorbidity Between Attention Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder Across the Lifespan: A Systematic and Critical Review.

Abramovitch A, Dar R, Mittelman A, Wilhelm S.

Harv Rev Psychiatry. 2015 Jul-Aug;23(4):245-62. doi: 10.1097/HRP.0000000000000050. Review.

15.

Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?

Wheaton MG, Rosenfield D, Foa EB, Simpson HB.

J Consult Clin Psychol. 2015 Oct;83(5):926-37. doi: 10.1037/ccp0000025. Epub 2015 May 25.

16.
17.

Transcranial direct current stimulation in psychiatric disorders.

Tortella G, Casati R, Aparicio LV, Mantovani A, Senço N, D'Urso G, Brunelin J, Guarienti F, Selingardi PM, Muszkat D, Junior Bde S, Valiengo L, Moffa AH, Simis M, Borrione L, Brunoni AR.

World J Psychiatry. 2015 Mar 22;5(1):88-102. doi: 10.5498/wjp.v5.i1.88. Review.

18.

Assessment and management of treatment-refractory obsessive-compulsive disorder in children.

Bloch MH, Storch EA.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):251-62. doi: 10.1016/j.jaac.2015.01.011. Epub 2015 Jan 30. Review.

19.

A direct GABAergic output from the basal ganglia to frontal cortex.

Saunders A, Oldenburg IA, Berezovskii VK, Johnson CA, Kingery ND, Elliott HL, Xie T, Gerfen CR, Sabatini BL.

Nature. 2015 May 7;521(7550):85-9. doi: 10.1038/nature14179. Epub 2015 Mar 4.

20.

Aripiprazole versus quetiapine in treatment-resistant obsessive-compulsive disorder: a double-blind clinical trial.

Shoja Shafti S, Kaviani H.

Ther Adv Psychopharmacol. 2015 Feb;5(1):32-7. doi: 10.1177/2045125314560739.

Supplemental Content

Support Center